Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
ConditionOptic Neuropathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The purpose of this study is to test the efficacy and feasibility of an intervention protocol for home-based repetitive transorbital alternating current stimulation (rtACS) for the treatment of visual impairment in people with optic neuropathy. The primary aims are to evaluate the effectiveness of home-based rtACS to ameliorate the progressive effects of vision loss functionally in the eye and the visual pathway, and in regard to people's independence (i.e., functional ability).
Eligibility criteria
Qualifiers
Age equal to or over 18 years old
Must have a permanent residence
Diagnosis of optic neuropathy
VF defects present in at least one eye (MD ≤ -3.00 dB) FL, FP, FN <33%
Disqualifiers
High intraocular pressure (over 27 mmHg)
End-stage organ disease or medical condition with subsequent vision loss (e.g., diabetes, stroke)
Advanced or unstable retinal diseases
Pathological nystagmus
Trial design
Treatments tested in this trial
- SAVIR Alpha Synch mobile (SASm)
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov